0001209191-18-063590.txt : 20181219
0001209191-18-063590.hdr.sgml : 20181219
20181219195940
ACCESSION NUMBER: 0001209191-18-063590
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181217
FILED AS OF DATE: 20181219
DATE AS OF CHANGE: 20181219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shepard Jay
CENTRAL INDEX KEY: 0001587788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36361
FILM NUMBER: 181244470
MAIL ADDRESS:
STREET 1: 15977 GRANDVIEW AVENUE
CITY: MONTE SERENO
STATE: CA
ZIP: 95030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aravive, Inc.
CENTRAL INDEX KEY: 0001513818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264106690
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LYONDELLBASELL TOWER
STREET 2: 1221 MCKINNEY STREET, SUITE 3200
CITY: HOUSTON
STATE: TX
ZIP: 77010
BUSINESS PHONE: 936-355-1910
MAIL ADDRESS:
STREET 1: LYONDELLBASELL TOWER
STREET 2: 1221 MCKINNEY STREET, SUITE 3200
CITY: HOUSTON
STATE: TX
ZIP: 77010
FORMER COMPANY:
FORMER CONFORMED NAME: Versartis, Inc.
DATE OF NAME CHANGE: 20110223
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-17
0
0001513818
Aravive, Inc.
ARAV
0001587788
Shepard Jay
C/O ARAVIVE, INC.
LYONDELLBASSELL TOWER, 1221 MCKINNEY ST.
HOUSTON
TX
77010
1
1
0
0
President and CEO
Common Stock
2018-12-17
4
S
0
11247
3.962
D
87597
D
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
The number of shares reflects the one-for-six reverse stock split effected by Aravive, Inc. on October 16, 2018.
/s/ Kevin Haas, Attorney-in-fact
2018-12-19